Claire Aldridge

Claire Aldridge

Private Equity Investor bij Capital Factory Management LLC

Consumer Services
Commercial Services
Finance

Profiel

Dr. Aldridge is Vice President, Venture Development for Remeditex Ventures.
She came to Remeditex from UTSW where she held numerous positions, most recently as Director, Commercialization Relations in the Office for Technology Development.
This office was responsible for the commercialization of scientific discoveries made by the clinical and research faculty.
Dr. Aldridge received her BS degree in Biomedical Science from Texas A&M University and her PhD in Immunology and Genetics from Duke University.

Actieve functies van Claire Aldridge

BedrijvenFunctieBegin
Private Equity Investor 01-01-2021
Corporate Officer/Principal 01-07-2022
Alle actieve functies van Claire Aldridge

Eerdere bekende functies van Claire Aldridge

BedrijvenFunctieEinde
TAYSHA GENE THERAPIES, INC. Operationeel Directeur 01-04-2022
The University of Texas Southwestern Medical Center Corporate Officer/Principal 01-02-2021
Private Equity Investor 01-04-2019
The University of Texas Southwestern Medical Center Corporate Officer/Principal 01-07-2011
Corporate Officer/Principal 01-10-2005
Ervaring van Claire Aldridge in detail bekijken

Opleiding van Claire Aldridge

Texas A&M University Undergraduate Degree
Duke University School of Medicine Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Claire Aldridge in detail bekijken

Connecties

99

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
TAYSHA GENE THERAPIES, INC.

Health Technology

Bedrijven in privébezit5

Commercial Services

Commercial Services

Finance

Finance

Commercial Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Claire Aldridge